Proxalutamide
GT0918-CN-2001
Phase 1 small_molecule completed
Quick answer
Proxalutamide for Metastatic Breast Cancer is a Phase 1 program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Metastatic Breast Cancer
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed